These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8876709)

  • 1. Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas.
    Bonkhoff H; Stein U; Aumüller G; Remberger K
    Prostate; 1996 Oct; 29(4):261-7. PubMed ID: 8876709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
    Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Messenger RNA levels and enzyme activities of 5 alpha-reductase types 1 and 2 in human benign prostatic hyperplasia (BPH) tissue.
    Shirakawa T; Okada H; Acharya B; Zhang Z; Hinata N; Wada Y; Uji T; Kamidono S; Gotoh A
    Prostate; 2004 Jan; 58(1):33-40. PubMed ID: 14673950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M; Bartsch W; Thomsen M; Voigt KD
    J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.
    Thomas LN; Douglas RC; Vessey JP; Gupta R; Fontaine D; Norman RW; Thompson IM; Troyer DA; Rittmaster RS; Lazier CB
    J Urol; 2003 Nov; 170(5):2019-25. PubMed ID: 14532845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism.
    Ji Q; Chang L; VanDenBerg D; Stanczyk FZ; Stolz A
    Prostate; 2003 Mar; 54(4):275-89. PubMed ID: 12539226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancer.
    Titus MA; Gregory CW; Ford OH; Schell MJ; Maygarden SJ; Mohler JL
    Clin Cancer Res; 2005 Jun; 11(12):4365-71. PubMed ID: 15958619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin increases 5alpha-reductase activity of human prostate epithelial cells, but not stromal cells.
    Assinder SJ
    Prostate; 2008 Feb; 68(2):115-21. PubMed ID: 18008328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 and type 2 5alpha-reductase expression in the development and progression of prostate cancer.
    Thomas LN; Douglas RC; Lazier CB; Too CK; Rittmaster RS; Tindall DJ
    Eur Urol; 2008 Feb; 53(2):244-52. PubMed ID: 18006217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5alpha-reductase isozymes and androgen actions in the prostate.
    Zhu YS; Imperato-McGinley JL
    Ann N Y Acad Sci; 2009 Feb; 1155():43-56. PubMed ID: 19250191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New aspects in histogenesis of hyperplasia and cancers of the prostate].
    Bonkhoff H; Remberger K
    Verh Dtsch Ges Pathol; 1993; 77():31-9. PubMed ID: 7511302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
    Yuan TC; Veeramani S; Lin FF; Kondrikou D; Zelivianski S; Igawa T; Karan D; Batra SK; Lin MF
    Endocr Relat Cancer; 2006 Mar; 13(1):151-67. PubMed ID: 16601285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a quantitative RT-PCR method to study 5alpha-reductase mRNA isozymes in rat prostate in different androgen status.
    Torres JM; Ruiz E; Ortega E
    Prostate; 2003 Jun; 56(1):74-9. PubMed ID: 12746849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of type I and type II 5alpha-reductase isoenzymes in prostate cancer tissues].
    Ye L; Zhang Y; Fang Z
    Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1504-7. PubMed ID: 16200776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activity of 5 alpha-reductase in human hyperplastic prostates].
    Lin Y
    Zhonghua Yi Xue Za Zhi; 1991 May; 71(5):263-5, 20. PubMed ID: 1713809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction.
    Rittmaster RS
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):389-402. PubMed ID: 18471794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid 5-alpha reductase type 2 activity in biopsies from malignant and normal prostatic tissues.
    Oliveira OL; Koff WJ; Muraro F; Santos EB; Gomes Soares DF; Trindade VM
    Clin Chim Acta; 2008 May; 391(1-2):36-40. PubMed ID: 18328817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.